Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5530)
HEALTHSTREAM INC (HSTM)
REBROVICK LINDA — Director
Shares
6,000
Price
$29.00
Total Value
$174.00K
Shares Held After
51,329
% of Holdings
10.5%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,270
Price
$14.00
Total Value
$31.78K
Shares Held After
90,180
% of Holdings
2.5%
Sight Sciences, Inc. (SGHT)
HAYDEN JEREMY B. — Chief Legal Officer
Shares
12,733
Price
$5.51
Total Value
$70.13K
Shares Held After
357,037
% of Holdings
3.4%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
2,087
Price
$57.76
Total Value
$120.55K
Shares Held After
104,395
% of Holdings
2.0%
Sight Sciences, Inc. (SGHT)
Badawi David — Director
Shares
7,418
Price
$5.51
Total Value
$40.86K
Shares Held After
1,982,872
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
7,913
Price
$57.16
Total Value
$452.28K
Shares Held After
106,482
% of Holdings
6.9%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
2,500
Price
$9.50
Total Value
$23.75K
Shares Held After
84,878
% of Holdings
2.9%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
6,229
Price
$5.26
Total Value
$32.76K
Shares Held After
2,834,982
% of Holdings
0.2%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$54.03
Total Value
$109.90K
Shares Held After
227,490
% of Holdings
0.9%
Elite Health Systems Inc. (EHSI)
jeereddi Prasad Anjaneya — Director
Shares
42,105
Price
$0.95
Total Value
$40.00K
Shares Held After
3,624,484
% of Holdings
1.2%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
146,889
Price
$22.45
Total Value
$3.30M
Shares Held After
1,019,658
% of Holdings
12.6%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
239,351
Price
$21.74
Total Value
$5.20M
Shares Held After
1,166,547
% of Holdings
17.0%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
410
Price
$7.01
Total Value
$2.87K
Shares Held After
86,380
% of Holdings
0.5%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
14,745
Price
$14.03
Total Value
$206.87K
Shares Held After
154,811
% of Holdings
8.7%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
85,955
Price
$14.03
Total Value
$1.21M
Shares Held After
707,373
% of Holdings
10.8%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
25,000
Price
$37.39
Total Value
$934.63K
Shares Held After
60,000
% of Holdings
29.4%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
65,000
Price
$37.39
Total Value
$2.43M
Shares Held After
2,710,000
% of Holdings
2.3%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
16,072
Price
$23.44
Total Value
$376.73K
Shares Held After
15,805
% of Holdings
50.4%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
16,214
Price
$22.76
Total Value
$369.03K
Shares Held After
31,877
% of Holdings
33.7%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
22,714
Price
$21.95
Total Value
$498.57K
Shares Held After
48,091
% of Holdings
32.1%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
94
Price
$27.36
Total Value
$2.57K
Shares Held After
14,364
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
692
Price
$26.00
Total Value
$17.99K
Shares Held After
14,458
% of Holdings
4.6%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
85
Price
$27.27
Total Value
$2.32K
Shares Held After
23,884
% of Holdings
0.4%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
712
Price
$26.00
Total Value
$18.51K
Shares Held After
23,969
% of Holdings
2.9%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
24
Price
$27.33
Total Value
$655.81
Shares Held After
81,042
% of Holdings
0.0%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
534
Price
$26.03
Total Value
$13.90K
Shares Held After
81,066
% of Holdings
0.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
7,600
Price
$45.89
Total Value
$348.76K
Shares Held After
519,227
% of Holdings
1.4%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
4,282
Price
$45.43
Total Value
$194.53K
Shares Held After
526,827
% of Holdings
0.8%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
9,200
Price
$44.43
Total Value
$408.76K
Shares Held After
531,109
% of Holdings
1.7%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
1,506
Price
$4.27
Total Value
$6.43K
Shares Held After
94,630
% of Holdings
1.6%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
2,200
Price
$9.02
Total Value
$19.84K
Shares Held After
843,359
% of Holdings
0.3%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
222
Price
$9.07
Total Value
$2.01K
Shares Held After
732,603
% of Holdings
0.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
5,905
Price
$4.27
Total Value
$25.21K
Shares Held After
605,408
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
819
Price
$4.27
Total Value
$3.50K
Shares Held After
64,545
% of Holdings
1.3%
HEALTHEQUITY, INC. (HQY)
Fiore Michael Henry — EVP, CHIEF COMMERCIAL OFFICER
Shares
2,470
Price
$95.00
Total Value
$234.65K
Shares Held After
56,643
% of Holdings
4.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,859
Price
$4.27
Total Value
$7.94K
Shares Held After
157,703
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,036
Price
$4.27
Total Value
$4.42K
Shares Held After
91,428
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$524.99
Total Value
$787.49K
Shares Held After
45,321
% of Holdings
3.2%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
59,037
Price
$27.33
Total Value
$1.61M
Shares Held After
76,651
% of Holdings
43.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
200
Price
$650.15
Total Value
$130.03K
Shares Held After
17,303
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
1,541
Price
$519.00
Total Value
$799.78K
Shares Held After
11,001
% of Holdings
12.3%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
24,734
Price
$27.50
Total Value
$680.18K
Shares Held After
186,728
% of Holdings
11.7%
Butterfly Network, Inc. (BFLY)
Carlson Megan — CAO and SVP, Finance
Shares
41,303
Price
$7.96
Total Value
$328.94K
Shares Held After
465,906
% of Holdings
8.1%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
7,851
Price
$3.54
Total Value
$27.79K
Shares Held After
90,407
% of Holdings
8.7%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
19,225
% of Holdings
13.5%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP & CFO
Shares
3,313
Price
$86.00
Total Value
$284.92K
Shares Held After
177,543
% of Holdings
1.8%
ImmunityBio, Inc. (IBRX)
Cohen Cheryl — Director
Shares
131,210
Price
$9.50
Total Value
$1.25M
Shares Held After
125,386
% of Holdings
51.1%
Sight Sciences, Inc. (SGHT)
Rodberg James — Chief Financial Officer
Shares
6,902
Price
$5.36
Total Value
$36.99K
Shares Held After
224,037
% of Holdings
3.0%
Sight Sciences, Inc. (SGHT)
Bauerlein Alison — Chief Operating Officer
Shares
24,184
Price
$5.36
Total Value
$129.63K
Shares Held After
664,709
% of Holdings
3.5%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
10,000
Price
$1.98
Total Value
$19.80K
Shares Held After
366,904
% of Holdings
2.7%
Showing 1701–1750 of 5530 transactions (page 35 of 111)